Data / Form D filings / Gut-Brain-Axis Therapeutics Inc.
Gut-Brain-Axis Therapeutics Inc.: Form D filings
Gut-Brain-Axis Therapeutics Inc., a biotechnology company in Tempe, AZ, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on October 27, 2026, reports $2 million sold of a $20 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1340 E VINEDO LANE, Tempe, AZ, 85284
- Phone
- (480) 818-0741
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1996678
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Amendment | $20,000,000 | $1,965,000 | $18,035,000 | 22 | Oct 31, 2025 | sec.gov |
| Nov 6, 2025 | New notice | $20,000,000 | $1,965,000 | $18,035,000 | 22 | Oct 31, 2025 | sec.gov |
| Oct 10, 2023 | New notice | $8,000,000 | $1,425,000 | $6,575,000 | 23 | Sep 25, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James B. Adams | Executive Officer, Director | |
| Alexander Khoruts | Director | |
| Rosa Krajmalnik-Brown | Director | |
| Michael J. Sadowsky | Director |
Other biotechnology companies in Arizona that filed recently
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gut-Brain-Axis Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.